| Dr Lori Filichia Gentile, MD | |
|
9735 Kincey Ave Ste 205, Huntersville, NC 28078-9120 | |
| (980) 302-7150 | |
| (980) 302-7155 |
| Full Name | Dr Lori Filichia Gentile |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 16 Years |
| Location | 9735 Kincey Ave Ste 205, Huntersville, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336316751 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 2017-01156 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Health Presbyterian Medical Center | Charlotte, NC | Hospital |
| Novant Health Huntersville Medical Center | Huntersville, NC | Hospital |
| Novant Health Rowan Medical Center | Salisbury, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Presbyterian Hospital | 1153231907 | 359 |
| Novant Health Rowan Medical Center Llc | 3375452519 | 50 |
News Archive
The Committee for Medicinal Products for Human Use (CHMP) of the The European Medicines Agency (EMA) has recommended today to lift the EU-wide suspension of the marketing authorizations of both octagam® and octagam®10% which has been in place since September 2010, subject to certain conditions.
Cancer and stem cell biology researchers at the University of Colorado are launching the nation's first program focused on identifying and testing drugs that target and destroy cells thought to be at the root of cancer-cancer stem cells (CSCs).The Cancer Stem Cell-Directed Clinical Trials Program (CCTP) is a collaboration between the University of Colorado Cancer Center and the Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology, both located at the University of Colorado School of Medicine.
A childhood sleep-related breathing disorder (SRBD) is known to have negative consequences on cognitive development, behavior, quality of life and utilization of health care resources.
Novelos Therapeutics, Inc., a biopharmaceutical company developing therapeutics to treat cancer, announced that today a poster highlighting positive results in a Phase 2 trial of NOV-002 in combination with neoadjuvant chemotherapy treatment in patients with stage IIB-IIIC HER-2/neu negative invasive breast cancer is being presented by the Braman Family Breast Cancer Institute at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine at the AACR Breast Cancer Symposium in San Antonio, TX.
› Verified 9 days ago
| Entity Name | Novant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366409492 PECOS PAC ID: 1153234893 Enrollment ID: O20031121000692 |
News Archive
The Committee for Medicinal Products for Human Use (CHMP) of the The European Medicines Agency (EMA) has recommended today to lift the EU-wide suspension of the marketing authorizations of both octagam® and octagam®10% which has been in place since September 2010, subject to certain conditions.
Cancer and stem cell biology researchers at the University of Colorado are launching the nation's first program focused on identifying and testing drugs that target and destroy cells thought to be at the root of cancer-cancer stem cells (CSCs).The Cancer Stem Cell-Directed Clinical Trials Program (CCTP) is a collaboration between the University of Colorado Cancer Center and the Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology, both located at the University of Colorado School of Medicine.
A childhood sleep-related breathing disorder (SRBD) is known to have negative consequences on cognitive development, behavior, quality of life and utilization of health care resources.
Novelos Therapeutics, Inc., a biopharmaceutical company developing therapeutics to treat cancer, announced that today a poster highlighting positive results in a Phase 2 trial of NOV-002 in combination with neoadjuvant chemotherapy treatment in patients with stage IIB-IIIC HER-2/neu negative invasive breast cancer is being presented by the Braman Family Breast Cancer Institute at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine at the AACR Breast Cancer Symposium in San Antonio, TX.
› Verified 9 days ago
| Entity Name | The Presbyterian Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053365817 PECOS PAC ID: 1153231907 Enrollment ID: O20040223001121 |
News Archive
The Committee for Medicinal Products for Human Use (CHMP) of the The European Medicines Agency (EMA) has recommended today to lift the EU-wide suspension of the marketing authorizations of both octagam® and octagam®10% which has been in place since September 2010, subject to certain conditions.
Cancer and stem cell biology researchers at the University of Colorado are launching the nation's first program focused on identifying and testing drugs that target and destroy cells thought to be at the root of cancer-cancer stem cells (CSCs).The Cancer Stem Cell-Directed Clinical Trials Program (CCTP) is a collaboration between the University of Colorado Cancer Center and the Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology, both located at the University of Colorado School of Medicine.
A childhood sleep-related breathing disorder (SRBD) is known to have negative consequences on cognitive development, behavior, quality of life and utilization of health care resources.
Novelos Therapeutics, Inc., a biopharmaceutical company developing therapeutics to treat cancer, announced that today a poster highlighting positive results in a Phase 2 trial of NOV-002 in combination with neoadjuvant chemotherapy treatment in patients with stage IIB-IIIC HER-2/neu negative invasive breast cancer is being presented by the Braman Family Breast Cancer Institute at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine at the AACR Breast Cancer Symposium in San Antonio, TX.
› Verified 9 days ago
| Entity Name | Novant Health Rowan Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508931544 PECOS PAC ID: 3375452519 Enrollment ID: O20040422001655 |
News Archive
The Committee for Medicinal Products for Human Use (CHMP) of the The European Medicines Agency (EMA) has recommended today to lift the EU-wide suspension of the marketing authorizations of both octagam® and octagam®10% which has been in place since September 2010, subject to certain conditions.
Cancer and stem cell biology researchers at the University of Colorado are launching the nation's first program focused on identifying and testing drugs that target and destroy cells thought to be at the root of cancer-cancer stem cells (CSCs).The Cancer Stem Cell-Directed Clinical Trials Program (CCTP) is a collaboration between the University of Colorado Cancer Center and the Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology, both located at the University of Colorado School of Medicine.
A childhood sleep-related breathing disorder (SRBD) is known to have negative consequences on cognitive development, behavior, quality of life and utilization of health care resources.
Novelos Therapeutics, Inc., a biopharmaceutical company developing therapeutics to treat cancer, announced that today a poster highlighting positive results in a Phase 2 trial of NOV-002 in combination with neoadjuvant chemotherapy treatment in patients with stage IIB-IIIC HER-2/neu negative invasive breast cancer is being presented by the Braman Family Breast Cancer Institute at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine at the AACR Breast Cancer Symposium in San Antonio, TX.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lori Filichia Gentile, MD Po Box 60447, Charlotte, NC 28260-0447 Ph: () - | Dr Lori Filichia Gentile, MD 9735 Kincey Ave Ste 205, Huntersville, NC 28078-9120 Ph: (980) 302-7150 |
News Archive
The Committee for Medicinal Products for Human Use (CHMP) of the The European Medicines Agency (EMA) has recommended today to lift the EU-wide suspension of the marketing authorizations of both octagam® and octagam®10% which has been in place since September 2010, subject to certain conditions.
Cancer and stem cell biology researchers at the University of Colorado are launching the nation's first program focused on identifying and testing drugs that target and destroy cells thought to be at the root of cancer-cancer stem cells (CSCs).The Cancer Stem Cell-Directed Clinical Trials Program (CCTP) is a collaboration between the University of Colorado Cancer Center and the Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology, both located at the University of Colorado School of Medicine.
A childhood sleep-related breathing disorder (SRBD) is known to have negative consequences on cognitive development, behavior, quality of life and utilization of health care resources.
Novelos Therapeutics, Inc., a biopharmaceutical company developing therapeutics to treat cancer, announced that today a poster highlighting positive results in a Phase 2 trial of NOV-002 in combination with neoadjuvant chemotherapy treatment in patients with stage IIB-IIIC HER-2/neu negative invasive breast cancer is being presented by the Braman Family Breast Cancer Institute at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine at the AACR Breast Cancer Symposium in San Antonio, TX.
› Verified 9 days ago
Brett Baker, Surgery Medicare: Medicare Enrolled Practice Location: 11208 Statesville Rd Ste 300, Huntersville, NC 28078 Phone: 704-659-9000 | |
Dr. David Hardman Harley, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 13620 Reese Blvd E, Suite 110, Bldg Xii, Huntersville, NC 28078 Phone: 704-840-9151 | |
Martin J Carignan, MD Surgery Medicare: May Accept Medicare Assignments Practice Location: 14330 Oakhill Park Ln Ste 125, Huntersville, NC 28078 Phone: 704-659-4499 Fax: 800-878-1090 | |
Robert James Czuprynski, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 9930 Kincey Ave Ste 210, Huntersville, NC 28078 Phone: 704-316-3492 Fax: 704-316-2637 | |
Dr. Aaron Eli Bergsman, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 10030 Gilead Rd, Ste. 300, Huntersville, NC 28078 Phone: 704-895-9390 Fax: 704-895-7760 | |
David Langdon Walrath, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 10215 Hickorywood Hill Ave, Suite B, Huntersville, NC 28078 Phone: 704-947-7027 Fax: 704-947-2273 |